1. Introduction {#sec1}
===============

Superior mesenteric vein (SMV) or superior mesenteric-portal vein confluence (SMPV) tumor involvement without arterial involvement is not a sign of unresectable disease [@bib1]. A comparison of a group of patients who underwent pancreaticoduodenectomy (PD) with SMV or SMPV confluence resection and a group of patients who underwent standard PD found no difference in perioperative mortality (0 deaths in both groups), rate of positive resection margin (13 vs. 16%, *P* = 0.72), number of positive lymph nodes (42 vs. 52%, *P* = 0.38), median length of hospital stay (16 vs. 15 days, *P* = 0.39) and median survival (22 vs. 20 months, *P* = 0.25) [@bib2]. Thus, venous resection and reconstruction during PD is currently the standard of care in centers where surgeons have the experience for SMV or SMPV confluence resection and reconstruction [@bib1; @bib3]. The following methods for SMPV reconstruction have been reported: (1) patch angioplasty; (2) ligation of the splenic vein and primary portal vein and SMV anastomosis; (3) ligation of the splenic vein, and internal jugular vein interposition between the portal vein and the SMV; (4) primary portal vein and SMV anastomosis without division of the splenic vein; (5) internal jugular vein interposition between the portal vein and SMV without division of the splenic vein [@bib1].

The use of SMV ligation and primary anastomosis of the portal vein and splenic veins has not yet been reported for PD performed for pancreatic cancer. However, the trauma literature has documented patient survival is possible following ligation of the SMV due to the establishment of collateral circulation [@bib4; @bib5].

Here we report a case of ligation of the SMV, and primary portal vein and splenic vein anastomosis during PD.

2. Presentation {#sec2}
===============

A 62 year old Caucasian female presented with a three week history of jaundice, 7 pound unintended weight loss and mild epigastric abdominal pain. An endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound were performed and the ERCP showed a high-grade distal common bile duct stricture with proximal dilation. Stenting of the common bile duct was then performed. Endoscopic ultrasound showed a 33.6 × 24.9 mm mass in the head of the pancreas. The mass was abutting the portal vein and multiple vascular collaterals were noted raising the possibility of invasion of the vein. A fine needle aspiration was also consistent with a moderately differentiated ductal adenocarcinoma.

A triphasic CT scan also confirmed a 3 cm × 2.5 cm low attenuation mass located in the head of the pancreas with dilation of the main pancreatic duct. Adenopathy was also present around the celiac artery. However, the fatty tissue plane around the celiac axis and SMA was present. There were near complete obstruction of portal vein flow and significant venous collateral circulation development ([Fig. 1](#fig1){ref-type="fig"}).

3. Therapeutic intervention {#sec3}
===========================

Neoadjuvant chemoradiation therapy was performed with FOLFIRINOX protocol for three months.

A post neoadjuvant therapy CT scan showed a significant reduction of the size of the pancreatic mass from 3 cm × 2.5 cm to 2.3 cm × 2 cm, and the fatty tissues plane around the superior mesenteric and celiac arteries still remained. There were significant improvement of portal vein flow and diminished SMV collateral circulation ([Fig. 2](#fig2){ref-type="fig"}).

A pancreaticoduodenectomy (PD) was performed. The plane between the neck of the pancreas and the portal vein and the splenic vein were free from the tumor, but the tumor abutted the superior mesenteric vein close to the SMPV confluence, there was no SMV branch involvement. The SMV and SMPV confluence were then resected en-bloc with the tumor to achieve a negative margin ([Fig. 3](#fig3){ref-type="fig"}). There was 4 cm gap between SMV and portal vein. We initially reconstructed the portal vein and superior mesentery vein with a saphenous vein graft, which thrombosed immediately after anastomosis. We did not have a proper sized vein graft at this point, and were reluctant to use a synthetic graft for the potential risk of graft infection and thrombosis. We were also unwilling to take more time to harvest the internal jugular vein graft, as that would cause more bowel congestion. The splenic vein remnant was distended and adjacent to the portal vein stump. We were able to perform a primary anastomosis of the portal vein to the splenic vein free of tension. This anastomosis relieved the venous congestion of the bowel. In addition, this also allowed for the superior mesentery vein ligation and abdominal closure ([Fig. 4](#fig4){ref-type="fig"}). Had this anastomosis failed to relieve the venous congestion, we planned to place a synthetic graft between the portal vein and SMV, or to harvest an internal jugular vein graft, at the risk of prolonging the time of bowel venous congestion.

Postoperatively, patient was put on heparin weight based protocol until post-operative day 13; the patient had 8 days of transient ascites, but otherwise, underwent an uneventful postoperative course. She was discharged home on post-operative day 13 on a low fat diet.

3.1. Follow up and outcome {#sec3.1}
--------------------------

Final pathology report demonstrated a significant post neoadjuvant response with a residual ductal adenocarcinoma foci of \<5 mm. Lymph nodes were negative for metastasis (0/24) and all margins were negative for disease.

The patient was asymptomatic for one year, and then developed recurrent ascites. At that time a CT scan with IV contrast demonstrated thrombosis of the portal vein and extensive venous collateral circulation around the spleen. A PET/CT scan confirmed that she had developed bilateral lung and right femur metastasis. She expired 15 months post PD.

4. Timeline {#sec4}
===========

5. Discussion {#sec5}
=============

The results of SMV or SMPV confluence resection and reconstruction in patients with limited venous involvement are similar to the results in patients without venous involvement [@bib1; @bib3]. Reestablishing portal vein-SMV continuity remains the safest reconstruction technique. The venous graft of choice is the internal jugular vein auto graft [@bib1]. Internal jugular vein allo-graft is also becoming available. The alternative for the internal jugular vein graft is polytetrafluoroethylene (PTFE) graft, although a synthetic graft poses greater risk of thrombosis and infection [@bib6].

Direct SMV to portal vein anastomosis is possible if the gap between SMV and portal vein is less than 2 cm. The tension free anastomosis can be achieved by mobilizing liver.

We feel it was very fortunate that this patient\'s mesenteric venous congestion was relieved by the splenic-portal venous anastomosis. It is possible that venous collaterals secondary to SMV tumor obstruction may have allowed this patient\'s post-operative survival.

SMV ligation after SMV or SMPV confluence resection during PD is not recommended at this time. However, this case showed a patient may survive SMV ligation after SMPV confluence resection and portal vein-splenic vein reconstruction. We believe this case should be reported for future reference and research. We are reporting the case in line with the CARE Guidelines.
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![Pre-neoadjuvant therapy triphasic CT scan: 3.2 cm × 2.5 cm head of pancreatic mass caused SMV/portal vein obstruction and superior mesenteric vein collateral circulation development.](gr1){#fig1}

![Post-neoadjuvant therapy triphasic CT scan: Significant improvement of portal vein flow and diminished SMV collateral circulation.](gr2){#fig2}

![Illustration of SMV and SMPV resection. (SMV: superior mesenteric vein; SMPV: superior mesenteric portal vein confluence; SV: splenic vein; PV: portal vein).](gr3){#fig3}

![Illustration of PV and SV anastomosis, SMV ligation. (SMV: superior mesenteric vein; SV: splenic vein; PV: portal vein).](gr4){#fig4}
